NASDAQ:APLS Apellis Pharmaceuticals - APLS Insider Trading & Ownership Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Apellis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $64.98 -0.68 (-1.04%) (As of 03/28/2023 12:00 AM ET) Add Compare Share Share Today's Range$64.83▼$66.2250-Day Range$50.49▼$66.9652-Week Range$33.32▼$70.75Volume808,204 shsAverage Volume1.69 million shsMarket Capitalization$7.23 billionP/E RatioN/ADividend YieldN/APrice Target$78.40 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Apellis Pharmaceuticals (NASDAQ:APLS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.00%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)12Amount OfInsider Selling(Last 12 Months)$21.11 M APLS Insider Buying and Selling by Quarter Get APLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Apellis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Apellis Pharmaceuticals Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails3/21/2023Cedric FrancoisCEOSell30,000$62.74$1,882,200.001,144,591 3/17/2023Alec MachielsDirectorSell1,250$64.03$80,037.50267,641 3/8/2023Pascal DeschateletsInsiderSell12,000$63.79$765,480.001,020,813 2/23/2023Jeffrey EiseleInsiderSell1,646$68.76$113,178.9653,883 2/8/2023Pascal DeschateletsInsiderSell12,000$54.45$653,400.001,006,756 2/3/2023Adam J TownsendInsiderSell5,000$55.85$279,250.0067,932 1/30/2023Jeffrey EiseleInsiderSell883$52.76$46,587.0846,468 1/23/2023Karen LewisInsiderSell2,955$51.58$152,418.9037,709 1/17/2023Alec MachielsDirectorSell1,250$52.42$65,525.00267,641 1/9/2023Pascal DeschateletsInsiderSell12,000$46.08$552,960.00983,780 1/5/2023Federico GrossiInsiderSell2,500$48.79$121,975.0094,884 1/3/2023A. Sinclair DunlopDirectorSell500$50.70$25,350.00132,797 1/3/2023Adam J TownsendInsiderSell5,000$50.70$253,500.0042,907 12/19/2022Cedric FrancoisCEOSell28,200$52.06$1,468,092.00965,128 12/15/2022Alec MachielsDirectorSell1,250$52.35$65,437.50263,774 12/8/2022Pascal DeschateletsInsiderSell12,000$47.50$570,000.00970,280 12/5/2022Adam J TownsendInsiderSell5,000$50.38$251,900.0042,907 12/1/2022A. Sinclair DunlopDirectorSell500$49.93$24,965.00129,430 12/1/2022Federico GrossiInsiderSell2,500$49.93$124,825.0097,384 11/8/2022Pascal DeschateletsInsiderSell12,000$46.47$557,640.00963,780 11/3/2022Adam J TownsendInsiderSell5,000$58.54$292,700.0042,907 10/14/2022Alec MachielsDirectorSell1,250$59.31$74,137.50263,774 10/10/2022Pascal DeschateletsInsiderSell12,000$57.50$690,000.00957,280 10/3/2022Federico GrossiInsiderSell2,500$66.69$166,725.00102,384 9/15/2022Alec MachielsDirectorSell1,250$66.00$82,500.00263,774 9/8/2022Pascal DeschateletsInsiderSell12,000$63.98$767,760.00950,780 8/17/2022Mark Jeffrey DelongSVPSell5,000$69.50$347,500.0029,250 8/15/2022Adam J TownsendInsiderSell12,500$69.00$862,500.0042,907 8/15/2022Alec MachielsDirectorSell1,250$67.21$84,012.50263,774 8/11/2022A. Sinclair DunlopDirectorSell30,000$65.63$1,968,900.00255,679 8/11/2022Adam J TownsendInsiderSell12,500$67.00$837,500.0042,907 8/11/2022Mark Jeffrey DelongSVPSell5,000$67.00$335,000.0029,250 8/3/2022Adam J TownsendInsiderSell5,000$56.43$282,150.0037,907 8/1/2022Federico GrossiInsiderSell2,500$55.99$139,975.00107,384 7/27/2022Mark Jeffrey DelongSVPSell5,000$57.00$285,000.0029,250 7/19/2022Mark Jeffrey DelongSVPSell5,000$56.42$282,100.0029,250 7/15/2022Alec MachielsDirectorSell1,250$46.33$57,912.50263,774 7/11/2022Adam J TownsendInsiderSell5,000$48.42$242,100.0042,907 7/8/2022Pascal DeschateletsInsiderSell12,000$47.95$575,400.00937,780 6/27/2022A. Sinclair DunlopDirectorSell1,341$46.79$62,745.391,341 6/23/2022A. Sinclair DunlopDirectorSell15,000$45.00$675,000.00285,679 6/22/2022David O WatsonGeneral CounselSell10,000$44.51$445,100.00115,569 6/17/2022Victoria L BrownInsiderSell2,698$45.00$121,410.0024,974 6/16/2022Mark Jeffrey DelongSVPSell10,000$41.78$417,800.0029,250 6/15/2022Alec MachielsDirectorSell1,250$39.29$49,112.50263,774 6/8/2022Pascal DeschateletsInsiderSell12,000$44.09$529,080.00891,775 6/1/2022Federico GrossiInsiderSell2,500$41.78$104,450.00109,561 5/27/2022Lukas ScheiblerInsiderSell10,000$43.00$430,000.0040,358 5/16/2022Alec MachielsDirectorSell1,250$39.18$48,975.00263,774 5/2/2022Federico GrossiInsiderSell2,500$43.56$108,900.00112,061 4/29/2022Pascal DeschateletsInsiderSell4,000$44.43$177,720.00891,775 4/25/2022David O WatsonGeneral CounselSell5,000$50.00$250,000.00125,569 4/20/2022Mark Jeffrey DelongSVPSell7,000$52.53$367,710.0028,481 4/14/2022Alec MachielsDirectorSell1,250$50.90$63,625.00263,774 4/4/2022Lukas ScheiblerInsiderSell3,504$56.96$199,587.8452,233 4/1/2022Lukas ScheiblerInsiderSell11,496$55.05$632,854.8052,233 (Data available from 1/1/2013 forward) APLS Insider Trading Activity - Frequently Asked Questions Who is on Apellis Pharmaceuticals's Insider Roster? The list of insiders at Apellis Pharmaceuticals includes A. Sinclair Dunlop, Adam J Townsend, Alec Machiels, Cedric Francois, David O Watson, Federico Grossi, Jeffrey Eisele, Karen Lewis, Lukas Scheibler, Mark Jeffrey Delong, Morningside Venture Investment, Nicole D Perry, Pascal Deschatelets, Victoria L Brown. Learn more on insiders at APLS. What percentage of Apellis Pharmaceuticals stock is owned by insiders? 8.00% of Apellis Pharmaceuticals stock is owned by insiders. Learn more on APLS's insider holdings. Which Apellis Pharmaceuticals insiders have been buying company stock? The following insider purchased APLS shares in the last 24 months: Morningside Venture Investment ($10,000,000.00). How much insider buying is happening at Apellis Pharmaceuticals? Insiders have purchased a total of 250,000 APLS shares in the last 24 months for a total of $10,000,000.00 bought. Which Apellis Pharmaceuticals insiders have been selling company stock? The following insiders have sold APLS shares in the last 24 months: A. Sinclair Dunlop ($10,935,082.49), Adam J Townsend ($3,301,600.00), Alec Machiels ($1,260,450.00), Cedric Francois ($3,350,292.00), David O Watson ($1,258,699.51), Federico Grossi ($986,186.00), Jeffrey Eisele ($159,766.04), Karen Lewis ($152,418.90), Lukas Scheibler ($2,042,864.95), Mark Jeffrey Delong ($2,532,250.00), Nicole D Perry ($167,950.00), Pascal Deschatelets ($6,537,815.00), and Victoria L Brown ($121,410.00). How much insider selling is happening at Apellis Pharmaceuticals? Insiders have sold a total of 608,171 Apellis Pharmaceuticals shares in the last 24 months for a total of $32,806,784.89 sold. This page (NASDAQ:APLS) was last updated on 3/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.